Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci. (Q39472017)
Jump to navigation
Jump to search
scientific article published on October 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci. |
scientific article published on October 1999 |
Statements
Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci (English)
M J Ferrándiz
J Oteo
B Aracil
J L Gómez-Garcés
1 October 1999